You are here

Evolus

AbbVie expects Botox to maintain market share as competition heats up

Reuters

Wed, 01/10/24 - 06:24 pm

Revance Therapeutics

US consumer group seeks stronger warnings on Botox, similar treatments

Reuters

Tue, 12/12/23 - 10:02 am

Revance Therapeutics

Supernus Pharmaceuticals

Biopharma’s stock market winners of 2021 revealed

EP Vantage

Wed, 01/12/22 - 10:50 am

Moderna Therapeutics

Bicycle Therapeutics

Can Evolus Disrupt the Botox Market?

Motley Fool

Mon, 07/5/21 - 09:47 pm

AbbVie puts an end to Botox trade secrets suit, imposes royalty, license deal on competitor Evolus

Endpoints

Fri, 02/19/21 - 10:43 am

AbbVie's Botox wins reprieve as agency bars Evolus' Jeaveau for alleged trade-secrets theft

Fierce Pharma

Thu, 12/17/20 - 06:26 pm

AbbVie draws first blood in trade secrets war between Allergan's Botox and Evolus

Fierce Pharma

Wed, 07/8/20 - 11:52 pm

Daewoong Pharmaceuticals

Evolus sparks controversy with Cancun beach bash ahead of Jeuveau launch

Fierce Pharma

Thu, 05/16/19 - 11:43 pm

Evolus' Botox competitor is here. Will it dent Allergan's sales?

Fierce Pharma

Mon, 02/4/19 - 08:52 pm

Mark Your Calendar For These February PDUFA Dates

Yahoo/Benzinga

Sat, 02/2/19 - 12:31 pm

MOTIF BIO PLC/S ADR

FDA stiff arms Evolus’ rival to Allergan’s blockbuster Botox, but execs promise a snap response

Endpoints

Wed, 05/16/18 - 09:35 am

Evolus says its Botox biosimilar could be delayed by FDA issues with Daewoong plant

Fierce Pharma

Thu, 01/25/18 - 05:56 pm

drug manufacturing

Look out, Allergan: Doctor surveys show the 'Botox competitive threat is real'

Fierce Pharma

Fri, 01/19/18 - 10:03 am

Revance Therapeutics

Boasting a late-stage Botox me-too, Evolus files for $75M IPO

Endpoints

Tue, 01/9/18 - 04:40 pm